Osaic Holdings’s Japer Therapeutics Warrants JSPRW Stock Holding History
Bought
Maintained
Sold
Other funds holding JSPRW
CAC
ICM
TCM
CL
ZA
Osaic Holdings's JSPRW Position: Q3 2023 in Review
Osaic Holdings sold out of Japer Therapeutics Warrants (JSPRW) in Q3 2023, closing a stake of 50 shares — an estimated $5 sold.
Osaic Holdings first reported a position in JSPRW in Q4 2022 and held it in 3 quarters. The position peaked at $10 in Q1 2023. 8 funds tracked by Wall St. Rank hold JSPRW as of Q3 2023.
- Osaic Holdings reported no remaining Japer Therapeutics Warrants position as of Q3 2023 after selling out during the quarter.
- Osaic Holdings sold 50 Japer Therapeutics Warrants shares in Q3 2023, an estimated $5.
- Osaic Holdings first reported a position in Japer Therapeutics Warrants in Q4 2022 and held it in 3 quarters.
- Osaic Holdings's Japer Therapeutics Warrants position peaked at $10 in Q1 2023.
- 8 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q3 2023.
Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.